Pyruvate kinase isoenzyme shift from L-type to M2-type is a late event in hepatocarcinogenesis induced in rats by a choline-deficient/DL-ethionine-supplemented diet
- PMID: 9472700
- DOI: 10.1093/carcin/19.1.99
Pyruvate kinase isoenzyme shift from L-type to M2-type is a late event in hepatocarcinogenesis induced in rats by a choline-deficient/DL-ethionine-supplemented diet
Abstract
Rats received a choline-deficient diet containing 0.1% (w/w) DL-ethionine (CDE) for 4, 10, 14 or 22 weeks. A separate group was treated for 4 weeks with CDE and then received a normal diet for 4 weeks. The L and M2 isoenzymes of pyruvate kinase were immunocytochemically demonstrated in liver sections. L-PK expression was strongly reduced in the hepatocytes after 4 weeks of treatment and remained low until the end of the study. Withdrawal of CDE after 4 weeks followed by 4 weeks normal diet resulted in a nearly full recovery of L-PK expression as compared to untreated controls. At later stages (10-22 weeks of CDE- treatment) many pseudolobules, preneoplastic foci of altered hepatocytes (FAH) such as combined clear/acidophilic cell foci (CCF/ACF) and mixed/basophilic cell foci (MCF/BCF), and hepatocellular adenomas (HCA) were observed. Pseudolobules showed a slight reduction in L-PK-expression, and were negative for M2-PK. In all clear cell components of CCF/ACF excessively storing glycogen, L-PK-expression was increased compared to both the surrounding parenchyma and hepatocytes of controls. In acidophilic cell components with less pronounced glycogen storage L-PK expression was similar to that of pseudolobules showing a slightly reduced content of this enzyme protein. M2-PK was invariably negative in CCF/ACF. In most MCF glycogen-storing subpopulations expressed L-PK, whereas in all glycogen-poor basophilic populations L-PK protein was strongly reduced. M2-PK was not expressed in most of these MCF. However, in rare MCF the reduction in L-PK expression was combined with a significant expression of M2-PK. In HCA M2-PK underwent a further increase, although to a variable degree, while L-PK remained strongly reduced. Our results show that an isoenzyme shift from L-PK to M2-PK takes place at a late stage of the hepatocarcinogenic process, and that those MCF with a low L-PK expression and a reexpression of M2-PK most probably represent the direct precursor lesions of hepatocellular neoplasms.
Similar articles
-
Expression of L- and M2-pyruvate kinases in proliferating oval cells and cholangiocellular lesions developing in the livers of rats fed a methyl-deficient diet.Carcinogenesis. 1994 Jan;15(1):125-7. doi: 10.1093/carcin/15.1.125. Carcinogenesis. 1994. PMID: 8293537
-
Persistence of the cholangiocellular and hepatocellular lesions observed in rats fed a choline-deficient/DL-ethionine-supplemented diet.Carcinogenesis. 1992 Feb;13(2):271-6. doi: 10.1093/carcin/13.2.271. Carcinogenesis. 1992. PMID: 1310907
-
Ethanol interactions with a choline-deficient, ethionine-supplemented feeding regime potentiate pre-neoplastic cellular alterations in rat liver.Carcinogenesis. 2002 Oct;23(10):1685-93. doi: 10.1093/carcin/23.10.1685. Carcinogenesis. 2002. PMID: 12376478
-
Significance of sequential cellular changes inside and outside foci of altered hepatocytes during hepatocarcinogenesis.Toxicol Pathol. 1989;17(4 Pt 1):617-28; discussion 629. doi: 10.1177/0192623389017004107. Toxicol Pathol. 1989. PMID: 2697940 Review.
-
Choline and hepatocarcinogenesis in the rat.Adv Exp Med Biol. 1995;375:65-74. doi: 10.1007/978-1-4899-0949-7_6. Adv Exp Med Biol. 1995. PMID: 7645429 Review.
Cited by
-
Regulation and targeting of SREBP-1 in hepatocellular carcinoma.Cancer Metastasis Rev. 2024 Jun;43(2):673-708. doi: 10.1007/s10555-023-10156-5. Epub 2023 Dec 1. Cancer Metastasis Rev. 2024. PMID: 38036934 Free PMC article. Review.
-
Modulation of type M2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein.Proc Natl Acad Sci U S A. 1999 Feb 16;96(4):1291-6. doi: 10.1073/pnas.96.4.1291. Proc Natl Acad Sci U S A. 1999. PMID: 9990017 Free PMC article.
-
Knockdown of the M2 Isoform of Pyruvate Kinase (PKM2) with shRNA Enhances the Effect of Docetaxel in Human NSCLC Cell Lines In Vitro.Yonsei Med J. 2016 Nov;57(6):1312-23. doi: 10.3349/ymj.2016.57.6.1312. Yonsei Med J. 2016. PMID: 27593857 Free PMC article.
-
Pyruvate kinase M2 fuels multiple aspects of cancer cells: from cellular metabolism, transcriptional regulation to extracellular signaling.Mol Cancer. 2018 Feb 19;17(1):35. doi: 10.1186/s12943-018-0791-3. Mol Cancer. 2018. PMID: 29455645 Free PMC article. Review.
-
Germline loss of PKM2 promotes metabolic distress and hepatocellular carcinoma.Genes Dev. 2016 May 1;30(9):1020-33. doi: 10.1101/gad.278549.116. Epub 2016 Apr 28. Genes Dev. 2016. PMID: 27125672 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous